StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 87M, up 21.5% from the year before. The highest annual figure on record is 87M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202587M+21.5%
FY2024Dec 31, 202472M+11.0%
FY2023Dec 31, 202364M+3.1%
FY2022Dec 31, 202263M+44.6%
FY2021Dec 31, 202143M+44.8%
FY2020Dec 31, 202030M–

More Cardiol Therapeutics figures

See a number that looks wrong?